Compare Heron Therapeutics Inc (HRTX) vs Msci Inc (MSCI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Msci Inc — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $61.47M), while Msci Inc trades at $562 (market cap $40.84B). The key difference: Msci Inc is far larger — about 664.4× Heron Therapeutics Inc's market cap, and Msci Inc pays a 1.46% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | MSCI | |
|---|---|---|
Market Cap | $61.47M | $40.84B |
Sector | Health | Financials |
52-Week High | $1.49 | $643.83 |
52-Week Low | $0.32 | $511.84 |
Enterprise Value | $168.21M | $47.00B |
Dividend Yield | — | 1.46% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Msci Inc
MSCI describes its mission as enabling investors to build better portfolios for a better world. MSCI's largest and most profitable segment is its index segment, where it provides benchmarking to asset managers and asset owners. In addition, it boasts over $1 trillion in ETF assets linked to MSCI indexes. The MSCI analytics segment provides portfolio management and risk management analytics software to asset managers and asset owners. MSCI's all other segment was broken out into ESG and climate and private assets segments in 2021. In ESG and climate, MSCI provides ESG data to the investment industry. In the private assets side, MSCI provides real restate reporting, market data, benchmarking, and analytics to investors and real estate managers.
Read more on MSCI →
